Journal
GASTROENTEROLOGY RESEARCH AND PRACTICE
Volume 2021, Issue -, Pages -Publisher
HINDAWI LTD
DOI: 10.1155/2021/6612892
Keywords
-
Categories
Funding
- National Natural Science Foundation of China [81572438]
Ask authors/readers for more resources
Liver fibrosis is a key factor in the development of liver cirrhosis and hepatocellular carcinoma, and understanding its mechanisms has led to new opportunities for treatment. Different potential therapies such as drug treatment, cell therapy, and liver transplantation offer a variety of treatment options for liver fibrosis.
Liver fibrosis resulting from chronic liver injury is a key factor to develop liver cirrhosis and risk of hepatocellular carcinoma (HCC) which are major health burden worldwide. Therefore, it is necessary for antifibrotic therapies to prevent chronic liver disease progression and HCC development. There has been tremendous progress in understanding the mechanisms of liver fibrosis in the last decade, which has created new opportunities for the treatment of this condition. In this review, we aim to make an overview on information of different potential therapies (drug treatment, cell therapy, and liver transplantation) for the liver fibrosis and hope to provide the therapeutic options available for the treatment of liver fibrosis and discuss novel approaches.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available